✦ LIBER ✦

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

✍ Scribed by Thierry Roumeguère; K. Zouaoui Boudjeltia; Claude Hauzeur; Claude Schulman; Michel Vanhaeverbeek; Eric Wespes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-clinical evidence for the use of pho

✍ Hanna Tinel; Beatrix Stelte-Ludwig; Joachim Hütter; Peter Sandner 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

The role of combination therapy for lowe

✍ Chris M. Gonzalez; Kevin T. McVary 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 259 KB

The role of combination therapy for lowe

✍ Chris M. Gonzalez; Kevin T. McVary 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 251 KB

Lasers for lower urinary tract symptoms

✍ Werner W. Hochreiter; Roger M. Müller 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 595 KB

Combination 5-α-reductase inhibitors and

✍ Joseph C. Clarke; Timothy R. Yoost; Harry S. Clarke 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 162 KB

Combination 5-α-reductase inhibitors and

✍ Joseph C. Clarke; Timothy R. Yoost; Harry S. Clarke 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 218 KB